Evidence Watch Long-acting injectable vs oral antipsychotics in bipolar disorder: should LAIs come earlier? A 20-year Hong Kong study of 2,086 patients, read for the prescriber: the answer first, then the questions you’d ask. Harvinder Singh, MD ·…
FDA Approved Subcutaneous Olanzapine LAI: What Prescribers Need to Know vs. Zyprexa Relprevv Harvinder Singh, MD · Psychiatry Education Forum · October 9, 2026 New FDA approval · October 9, 2026 For 17 years, long-acting olanzapine has meant…
Can a Patient Be Lithium-Toxic With a “Normal” Level — and Why Does the Number Mislead? HS Dr. Harvinder Singh, MD Board-certified psychiatrist · Psychiatry Education Forum Live: Section 1 of Managing Mood Stabilizer Adverse Events. Chapter 1,…
Evidence Watch Lithium or valproate after a first manic episode? A new Taiwanese cohort found more readmissions on lithium. The detail in its supplement changes how to read that result. Harvinder Singh, MD · Board-certified psychiatrist · Psychiatry…
Let’s Do It Together
Subscribe To The Blog
Report
There was a problem reporting this post.
Block Member?
Please confirm you want to block this member.
You will no longer be able to:
Mention this member in posts
Message this member
Add this member as a connection
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.
Evidence Watch Long-acting injectable vs oral antipsychotics in bipolar disorder: should LAIs come earlier? A 20-year Hong Kong study of 2,086 patients, read for the prescriber: the answer first, then the questions you’d ask. Harvinder Singh, MD ·…
